HUM Humana
- 335.590
- +0.910+0.27%
- 336.750
- +1.160+0.35%
Humana News
CVS Stock Is Dirt Cheap. That Doesn't Make It a Buy. -- Barrons.com
By Ian Salisbury Shares of CVS Health just went on sale. But like Valentine's candy in March, just because something is cheap, that doesn't make it a good buy. Shares of the convenience-store-turned
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.
$100 Invested In This Stock 20 Years Ago Would Be Worth $2,000 Today
Humana (NYSE:HUM) has outperformed the market over the past 20 years by 8.1% on an annualized basis producing an average annual return of 16.14%. Currently, Humana has a market capitalization of $38.4
Humana Names Successor to Outgoing President/CEO
Nordic care company Humana (HUM.ST) appointed Nathalie Boulas Nilsson as its new president and chief executive officer, effective July 22. Nilsson will succeed outgoing President and CEO Johanna Rasta
CVS Stock Discovers a Medicare Disadvantage -- Barrons.com
By Josh Nathan-Kazis and Jack Denton CVS Health caught a bad case of the Medicare Advantage blues this past week, blaming the program for its failure to meet quarterly-earnings expectations and slash
4 HMO Stocks to Watch Amid Persistent Industry Challenges
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.
Humana Up Nearly 6%, on Pace for Largest Percent Increase Since September 2022 -- Data Talk
Humana Inc. (HUM) is currently at $319.91, up $17.82 or 5.9% --Would be highest close since April 23, 2024, when it closed at $327.98 --On pace for largest percent increase since Sept. 15, 2022, whe
Peering Into Humana's Recent Short Interest
Humana's (NYSE:HUM) short percent of float has fallen 4.69% since its last report. The company recently reported that it has 2.45 million shares sold short, which is 2.03% of all regular shares that a
Concert Announces Clinical Advisory Board, New Medical Policies
Drs. Beth Harris, Thomas Holland, Girish Putcha, and Michele Schoonmaker join board to advise Concert on clinical policy content NASHVILLE, Tenn., May 1, 2024 /PRNewswire/ -- As part of its commitme
CVS Health Drops as Medical Cost Trends Prompt Guidance Cut
CVS Reports Earnings After Tricky Quarter for Managed Care -- Barrons.com
By Josh Nathan-Kazis When CVS Health reports earnings on Wednesday, investors will be watching what the company says about medical costs incurred by patients on its Medicare Advantage plans, a major
Top 50 Stocks With the Highest Sensitivity to Interest Rates Changes - GS
Analysts' Opinions Are Mixed on These Healthcare Stocks: Sanofi (OtherSNYNF), NewAmsterdam Pharma Company (NAMS) and Humana (HUM)
Deutsche Bank Adjusts Price Target on Humana to $341 From $355
Humana (HUM) has an average rating of outperform and price targets ranging from $326 to $550, according to analysts polled by Capital IQ. Price: 308.65, Change: -2.77, Percent Change: -0.89
This week's US bullish stocks | Performance and stock prices go hand in hand! Nvidia's exclusive liquid cooling supplier Vertiv surged more than 20% during the week
It was announced that it would accelerate the launch of cheap models, and Tesla had a cumulative increase of 15.73% during the week; database giant MongoDB surged nearly 12%, reaching 465 US dollars.
Buy Rating Affirmed for Humana Despite Earnings Forecast Adjustment: Growth and Fundamentals Remain Strong
Humana's Strong Q1 Performance and Cost Efficiency Bolster Buy Rating Despite 2025 Uncertainties
Analysts Revisit Humana Stock Price Targets Amid Medicare Advantage Hit
Molina Healthcare (MOH) Q1 Earnings Beat on Growing Membership
Analysis
Price Target
No Data
